VOLITIONRX LTD — Director's Dealing 2022

Aug 16, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2022-08-15-05:00

Reporting Person: Henshall Mickie (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-15-05:00	Common Stock	A	15000	—	Acquired	15000	Direct

Footnotes

F1: Ms. Henshall received restricted stock units subject to a 2-year vesting schedule, vesting as to 7,500 units on each of 08/15/23 and 08/15/24, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.